Lectures

ICNApedia is best viewed with any up-to-date browser with style sheets enabled.You will need Adobe® Flash Player (at least version 10.0.0) to view some of the content below. If not you will be redirected to the Flash Player download page. You may also download it here. Some content may be restricted to ICNA members or ICNC registrants. Please email administrator@icnapedia.org if you have any queries regarding this. If you would like to publish content on ICNApedia, please email your files to editor-at-icnapedia.org. Publishing with ICNApedia leaves the copyright with the author. All work is licensed under a Creative Commons Attribution-NonCommercial 2.0 Generic License.Disclaimer: ICNA speakers are expected to disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Opinions expressed with regard to unapproved uses of products are solely those of the speaker or faculty and are not endorsed by the International child neurology association or any manufacturers of pharmaceuticals. (Last updated January 11, 2017)
125 results - showing 31 - 40
« 1 2 3 4 5 6 ... »
Ordering
Details
ICNA
ICNA
Updated May 06, 2018 0 0
Read more
ICNA
ICNA
Updated May 06, 2018 0 0

Webinars

This video also includes the concluding discussion at the Zika Virus symposium following the lectures given at the 14th International Child Neurology Congress from May 1st – 5th, 2016 in Amsterdam, the Netherlands
Read more
ICNA
ICNA
Updated May 06, 2018 0 0
Dr Michael Johnston delivers the Frank Ford Award Lecture at the at the 14th International Child Neurology Congress from May 1st – 5th, 2016 in Amsterdam, the Netherlands. He is introduced by Prof Harry Chugani.
Read more
ICNA
ICNA
Updated May 06, 2018 0 0
Read more
ICNA
ICNA
Updated May 06, 2018 0 0
Read more
Monoclonal antibodies in Multiple Sclerosis
G Guest Updated January 30, 2016 0 1
The following table essentially highlights the relative efficacies of MS therapies. And you can see that the top four treatments, which are all monoclonal antibodies, have a higher efficacy. What you have to appreciate is most of these treatments have been tested against active comparators; therefore, the relative efficacy is much higher than those treatments that have been compared to placebo. The efficacy differential is present on relapses—this is the annualised reduction in relapse rate....
Read more
CV Christopher Verity Updated April 28, 2020 0 1
Read more
Bruce Cohen
G Guest Updated May 06, 2018 0 1
Read more
ICNA
ICNA
Updated May 06, 2018 0 2

Webinars

This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
Read more
125 results - showing 31 - 40
« 1 2 3 4 5 6 ... »